Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/2008
11/19/2008CN101306132A Medicine composition for treating Tourette syndrome and its preparation method
11/19/2008CN101306131A Duituizidian pill
11/19/2008CN101306130A Sanjialongdan Ruangan pill
11/19/2008CN101306118A Xuekangfu pill
11/19/2008CN101306117A Production of Qufu powder and Shengjizhangpi paste and evodia fruit paste
11/19/2008CN101306116A Xinnaoqingyu decoction
11/19/2008CN101306112A Baimaiyutong paster
11/19/2008CN101306111A Medicaments for treating animal trauma
11/19/2008CN101306110A Veterinary herbal medicine for preventing and treating hog cholera
11/19/2008CN101306109A Medicaments for treating pet burn and scald
11/19/2008CN101306107A Chinese traditional medicine composition for preventing and treating intestinal parasitical diseases of aquatic animal>
11/19/2008CN101306105A Medicament for preventing and treating puerperal hypogalactia
11/19/2008CN101306101A Medicine for treating thrombus and its preparation method
11/19/2008CN101306100A Medicine from external application for treating periglandular aphtha
11/19/2008CN101306092A Veterinary herbal medicine for treating poultry kidney abscess
11/19/2008CN101306082A Houkangsan quality control method
11/19/2008CN101306079A Decoction for treating poliomyelitis
11/19/2008CN101306077A Chinese traditional injection preparation for treating cancer and its preparation method
11/19/2008CN101306031A Chinese medicinal materials formulation for treating pneumoconiosis hemoptysis
11/19/2008CN101306024A Use of yew root in preparing medicine liquor for treating diabetes
11/19/2008CN101306020A Use of clostridium butyricum in preparing medicine composition for preventing and curing intestinal cancer
11/19/2008CN101306019A Hyper-concentrated placenta nano viable cell freeze-drying capsules and its preparation method
11/19/2008CN101306018A Hyper-concentrated placenta tissue hydrolysate freeze-drying capsules and its preparation method
11/19/2008CN101306017A Hyper-concentrated placenta lipopolysaccharide freeze-drying capsules and its preparation method
11/19/2008CN100434439C Genes and polypeptides relating to chronic myeloid leukemia
11/19/2008CN100434116C Chinese traditional medicine for external application of treating rheumatism like disease, preparation method and usage
11/19/2008CN100434115C Powder containing tuckahoe, seed of gordon euryale, coix seed and lotus seed
11/19/2008CN100434113C Medicinal composition for treating vertebrae lumbales hyperosteogeny
11/19/2008CN100434111C Powder containing seed of spine date, licorice and wheat
11/19/2008CN100434104C Spleen tonifying tea
11/19/2008CN100434097C Ophidia black snake powder
11/19/2008CN100434087C Compound oral prepn of muskone and total arasaponin and its application
11/19/2008CN100434086C Burn medicine
11/19/2008CN100434083C Medicinal use of fugu cod liver oil
11/18/2008US7452723 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
11/18/2008US7452716 Plasmid for use as gene transfer vechicle in the treatment of genetic disorders
11/18/2008US7452532 Transluminal application of adult stem cells for body organ tissue repair
11/18/2008US7452531 Compositions and methods for tumor-targeted delivery of effector molecules
11/18/2008US7452529 Treatment of muscular dystrophy with cord blood cells
11/18/2008CA2381219C Monomeric protein of the tgf-beta family
11/18/2008CA2375743C Methods and compositions for the support, regeneration and repair of connective tissues
11/18/2008CA2359338C Bacillus subtilis takemi and use thereof
11/18/2008CA2341614C Prolonged storage of red blood cells
11/18/2008CA2335686C Particulate acellular tissue matrix
11/18/2008CA2331404C Methods and apparatus for inactivating contaminants in biological fluid
11/18/2008CA2249361C Enhancement of microbial colonisation of the gastrointestinal tract
11/18/2008CA2186851C Use of mycobacteria for the treatment of tumours
11/18/2008CA2138594C Process for preparing clear sera which are stable over a long period
11/18/2008CA2124161C Pharmaceuticals for treating sepsis and septic shock
11/18/2008CA1341585C Recombinant retroviruses
11/16/2008CA2684215A1 Delivery of micro- and nanoparticles with blood platelets
11/13/2008WO2008138000A1 Spongy epithelial cell scaffold for vascularizing wounds
11/13/2008WO2008137917A1 Method of treating bacterial infections with antibacterial formulations
11/13/2008WO2008137747A1 Nanoemulsion therapeutic compositions and methods of using the same
11/13/2008WO2008137630A1 Use of hdac inhibitors for the treatment of gastrointestinal cancers
11/13/2008WO2008136733A1 Method and means for culturing osteoblastic cells
11/13/2008WO2008136730A1 Novel bacteria isolated from fresh honey or the honey producing tract of honey bees
11/13/2008WO2008136438A1 Viral vector for gene therapy
11/13/2008WO2008136213A1 Radiosensitivity-enhancing agent
11/13/2008WO2008134919A1 Ejaculum of animals as medicinal material and uses thereof in medicaments for treatment of diseases such as tumors, depression, etc.
11/13/2008WO2008134814A1 A method for treating inflammation and controlled-release material capable of providing same
11/13/2008WO2008134805A1 Novel thymic cellular populations and uses thereof
11/13/2008WO2008115069A3 Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents
11/13/2008WO2008110579A3 Adenovirus with mutations in the endoplasmic reticulum retention domain of the e3-19k protein and their use in cancer treatment.
11/13/2008WO2008107746A3 Tablet comprising microorganisms and a combination of excipients and the manufacture process thereof
11/13/2008WO2008099088A3 Method for the in vitro culture of t cells, in particular t cells infiltrating the so-called til tumours
11/13/2008WO2008085557A3 Alphavirus replicon particles encoding il- 12 as immunological adjuvants
11/13/2008WO2008013631A3 Composition for the enterosorption and management of toxins comprising a calcium aluminosilcilate clay
11/13/2008WO2007100543A3 Extracellular matrix to treat malignancy in mammals
11/13/2008WO2007054720A8 Reprogramming and genetic modification of cells
11/13/2008WO2007026356A3 Methods and compositions for prevention and treatment of diabetic and aged skin
11/13/2008US20080280822 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer
11/13/2008US20080280354 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
11/13/2008US20080279958 Snake venom compositions and methods of use
11/13/2008US20080279957 Pure extract from bovine bile; stimulant for monocytes and macrophages; in vitro; moderate tumor necrosis factor production; nontoxic to human blood cells; Aids therapy ; anticancer agents; multiple sclerosis; antiarthritic agents; lupus; antidiabetic agents; Crohn's disease; myasthenia gravis
11/13/2008US20080279956 Method for collecting a live placenta cord stem cell
11/13/2008US20080279945 Water soluble gel; gene expression of nucleic acid segments encoding therapy constructs including peptides, polypeptides, ribozymes and catalytic Rna to cells or tissues of animals; cardiovascular disorders; muscular dystrophy
11/13/2008US20080279941 Hydrogel substrate with porous surfaces; attaching biomaterials to living tissue; load bearing inserts; tissue repair and regeneration; disk prosthetics
11/13/2008US20080279939 Using a mixture of tissue sources; regeneration in situ
11/13/2008US20080279924 HLA class I A2 tumor associated antigen peptides and vaccine compositions
11/13/2008US20080279892 Attenuation of respiratory syncytial virus by mutagenisi of M2-1 gene; immunogenic composition
11/13/2008US20080279891 Viral Adjuvants
11/13/2008US20080279887 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug.
11/13/2008US20080279872 Using dendritic cells expressing chymotrypsin protein fragment as immunostimulatory tool for targeting cancer cells associated with ovarian tissue
11/13/2008US20080279869 Method for reducing neuronal degeneration by administering cns-derived peptides or activated t cells
11/13/2008US20080279866 Treating lymphomas, allergies and autoimmune diseases via apoptotic induction; using ATP-competitive inhibitor, 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one (KU-55933) and lymphocyte specific immunoglobulins
11/13/2008US20080279861 Method for stimulating a host immune system by administering an allogeneic cell material
11/13/2008US20080279836 Immobilizing labeled allogeneic T-cells to biodegradable micro/nanospheres; enhancing host immune response to tumors, viruses and bacterial pathogens
11/13/2008US20080279835 Using human umbilical cord progenitor cells to propagate myocardial tissues to treat coronary disease; tissue engineering and repair; regenerative medicine
11/13/2008US20080279834 Methods and Reagents for Identifying/Isolating T Regulatory (Treg) Cells and for Treating Individuals
11/13/2008US20080279833 Solid support comprising mammalian extracellular matrix for use in propagation of embryonic stem cell for use in treatment and repair of heart, pancreatic a nd/or liver tissues; tissue engineering and repair; regenerative medicine; wound healing agents
11/13/2008US20080279832 Osteogenic differentiation of preosteoblastic cells
11/13/2008US20080279831 Methods and compositions for identifying prostate cancer or a humoral immune response against prostate cancer
11/13/2008US20080279830 Solid support comprising propagating mesenchymal tissue for use in enhancing recovery from surgery; tissue engineering; regenerative medicine
11/13/2008US20080279829 Phenyl-(4-Phenyl-Pyrimidin-2-Yl)-Amines For Enhancing Immunotolerance
11/13/2008US20080279828 Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
11/13/2008US20080279827 Preparation and xenotransplantation of porcine islets
11/13/2008US20080279826 Propagating lymphocytes in presence of rapamycin, transplanting in to mammals, monitoring graft rejection; immunosuppression; immunotherapy
11/13/2008US20080279825 Cartilage material
11/13/2008US20080279824 Articles for tissue regeneration with biodegradable polymer